Health AI Central
Peer-Reviewed Publication
Gynecol Endocrinol2026;42(1):2732395.December 31, 2026Journal Article

Bone mineral density, body composition, sex hormone levels, and insulin sensitivity in patients with Polyendocrine Metabolic Ovarian Syndrome.

Caroline P Lopes1, Gustavo Ar Maciel1, Giovana Dn Maffazioli1, Peter Chedraui1,2, Renata Macchione1, Erika Mendonça das Neves1, José Maria Soares-Jr1, Rosa Maria Rodrigues Pereira3, Edmund C Baracat1
1Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, BR, Brazil.
2Escuela de Postgrado en Salud, Universidad Espíritu Santo, Samborondón, Ecuador.
3Disciplina de Reumatologia, Departamento de Clinica Medica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
PubMed DOI

Abstract

OBJECTIVE: To evaluate bone mineral density (BMD), body composition, sex hormone levels, and insulin sensitivity in women with Polyendocrine Metabolic Ovarian Syndrome (PMOS) and compare these parameters with those of women without the syndrome. METHODS: This cross-sectional study included 51 women with PMOS diagnosed according to the Rotterdam criteria and 30 women without the syndrome. Clinical…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.